A Phase 1 interventional study of SMART System and Culture dish in Infertility, sponsored by Incept BioSystems, Inc.. Completed at 4 sites in United States. Open to female participants aged 21 Years to 35 Years. Per ClinicalTrials.gov, last updated 2010-09-09.
Sponsored by Incept BioSystems, Inc. · Phase 1, Interventional, and Treatment
The purpose of this study is to compare the development of human embryos grown in a conventional culture dish to those grown in a new embryo culture device known as the SMART System.
This study is a multi-center, randomized, performance study.
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's planned enrollment of 40 is below the median of 120 across 1,698 interventional studies indexed under Infertility.
Browse Infertility studies →This is the only study on the registry with Incept BioSystems, Inc. as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria - All recruited subjects must meet all of the following inclusion criteria to be enrolled in the study:
Exclusion Criteria- Potential subjects are excluded from the study if any of the following conditions exist:
Embryos cultured in SMART System
Device: SMART System
Embryos cultured in microdrops in dishes
Device: Culture dish
microfluidic embryo culture system
Also known as: System for Microfluidically-Assisted Reproductive Technology
Standard IVF culture dish
Also known as: dish
rate of development of human embryos
Time frame: Day 3 (t=72 hrs)
This study is completed, as verified in Sep 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.